Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$456M |
| 2 |
SW
Smurfit Westrock
SW
|
+$403M |
| 3 |
Walt Disney
DIS
|
+$391M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$345M |
| 5 |
EPAM Systems
EPAM
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$671M |
| 2 |
Nike
NKE
|
+$557M |
| 3 |
Microchip Technology
MCHP
|
+$544M |
| 4 |
Visa
V
|
+$535M |
| 5 |
Becton Dickinson
BDX
|
+$487M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.06% |
| 2 | Financials | 10.52% |
| 3 | Healthcare | 9.63% |
| 4 | Industrials | 8.45% |
| 5 | Consumer Discretionary | 7.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Vita Coco
COCO
$3.75B
| $49.4M | 0.01% |
1,743,395
-6,910
| -0.4% | -$184K |
|
852
Zions Bancorporation
ZION
$10.5B
| $49.3M | 0.01% |
1,043,896
-74,350
| -7% | -$3.52M |
|
853
Incyte
INCY
$24.3B
| $49.1M | 0.01% |
742,992
-24,081
| -3% | -$1.54M |
|
854
Invesco FTSE RAFI Emerging Markets ETF
PXH
$1.96B
| $49M | 0.01% |
2,233,244
-72,143
| -3% | -$1.48M |
|
855
Domino's
DPZ
$12.1B
| $49M | 0.01% |
113,961
-12,617
| -10% | -$5.48M |
|
856
Delta Air Lines
DAL
$61.3B
| $49M | 0.01% |
964,124
-15,955
| -2% | -$695K |
|
857
iShares Global Tech ETF
IXN
$8.77B
| $48.9M | 0.01% |
592,276
-152,360
| -20% | -$12.3M |
|
858
Novartis
NVS
$294B
| $48.9M | 0.01% |
424,828
-22,846
| -5% | -$2.59M |
|
859
SS&C Technologies
SSNC
$18.6B
| $48.8M | 0.01% |
658,160
+1,892
| +0.3% | +$134K |
|
860
Columbia Short Duration Bond ETF
SBND
$206M
| $48.7M | 0.01% |
2,586,393
| – | – |
|
861
Dover
DOV
$28.3B
| $48.6M | 0.01% |
253,540
+12,779
| +5% | +$2.33M |
|
862
Bank of America Series L
BAC.PRL
$3.99B
| $48.6M | 0.01% |
38,191
+20
| +0.1% | +$24.6K |
|
863
Snowflake
SNOW
$110B
| $48.6M | 0.01% |
423,097
+65,648
| +18% | +$8.07M |
|
864
Knife River
KNF
$3.85B
| $48.5M | 0.01% |
542,903
+156,103
| +40% | +$12.2M |
|
865
Invesco S&P MidCap Momentum ETF
XMMO
$7.4B
| $48.5M | 0.01% |
402,582
-46,829
| -10% | -$5.43M |
|
866
Celestica
CLS
$41.7B
| $48.4M | 0.01% |
947,761
+317,786
| +50% | +$16.4M |
|
867
iShares MSCI Taiwan ETF
EWT
$10.6B
| $48.4M | 0.01% |
927,405
+295,388
| +47% | +$15.7M |
|
868
monday.com
MNDY
$3.87B
| $48.4M | 0.01% |
174,246
+10,178
| +6% | +$2.52M |
|
869
FTI Consulting
FCN
$4.23B
| $48.3M | 0.01% |
212,271
-16,231
| -7% | -$3.61M |
|
870
iShares MSCI Italy ETF
EWI
$1.07B
| $48.2M | 0.01% |
1,238,174
+396,494
| +47% | +$14.9M |
|
871
Structure Therapeutics
GPCR
$3.59B
| $48.2M | 0.01% |
1,097,451
+690,607
| +170% | +$26.7M |
|
872
Expeditors International
EXPD
$23.6B
| $48.1M | 0.01% |
366,027
-129,384
| -26% | -$15.8M |
|
873
CBRE Group
CBRE
$43.8B
| $48M | 0.01% |
385,357
+109,482
| +40% | +$11.9M |
|
874
Steris
STE
$22.7B
| $47.7M | 0.01% |
196,461
-6,881
| -3% | -$1.61M |
|
875
Paylocity
PCTY
$8.18B
| $47.5M | 0.01% |
287,892
+10,691
| +4% | +$1.63M |
|
Similar funds
Ameriprise's Q3 2024 Portfolio in Review
As of Q3 2024, Ameriprise held 4,064 positions worth $390B, up 5.5% from $370B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ameriprise's Q3 2024 filing shows 197 new, 1,617 increased, 1,938 reduced and 141 closed positions. Its largest new stake was Smurfit Westrock: 8,854,270 shares worth $438M. The largest sale was Apple, an estimated $671M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q3 2024 buy was Smurfit Westrock: 8,854,270 shares worth $438M.
- Ameriprise added most to UnitedHealth in Q3 2024, an estimated $456M increase.
- Ameriprise's biggest Q3 2024 reduction was Apple, cutting an estimated $671M.
- Ameriprise fully exited Cerevel Therapeutics Holdings, Inc. Common Stock in Q3 2024, selling an estimated $55.1M.
- Ameriprise's ten largest holdings make up 19% of its $390B portfolio in Q3 2024.
- Ameriprise opened 197 new positions and closed 141 in Q3 2024.
- Ameriprise's portfolio value rose 5.5% quarter-over-quarter to $390B.
Based on Ameriprise's 13F filing for Q3 2024, filed 14 Nov 2024.